<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="337">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 10, 2022</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01312363</url>
  </required_header>
  <id_info>
    <org_study_id>X-MEN</org_study_id>
    <nct_id>NCT01312363</nct_id>
  </id_info>
  <brief_title>Study for the Tolerability of Exelon Patch (Rivastigmine) for Alzheimer's Disease (AD) Patients</brief_title>
  <acronym>X-MEN</acronym>
  <official_title>A Six-month, Open Labeled, Multi-centered, Observational Study for the Tolerability of Exelon Patch (Rivastigmine) for Patients With Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seoul St. Mary's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Korea University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bobath Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chung-Ang University Hosptial, Chung-Ang University College of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hanyang University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kwandong University Myongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inha University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>SungAe General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ewha Womans University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hanyang University Seoul Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kyunghee University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hallym University Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pusan National University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Konyang University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wonkwang University Sanbon Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Yong-in Hyoja Geriatric Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Jeju National University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Dong-A University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators plan to see what factors can influence the durability of Exelon patch&#xD;
      treatment in Korean patients with Alzheimer's disease.&#xD;
&#xD;
      Based on these results, the investigators will find the ways to maximize the effect and&#xD;
      durability of Exelon patch on Korean patients with Alzheimer's disease.&#xD;
&#xD;
      After finishing this study, the investigators are going to present the study results at the&#xD;
      international and national academic meetings or conferences.&#xD;
&#xD;
      Also the investigators expect that they can publish the result in a journal of in the field&#xD;
      of neurology or dementia till the winter of 2010.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A once-daily Exelon patch has recently been developed to reduce the GI side effect of&#xD;
      rivastigmine and make application easier by once a day.&#xD;
&#xD;
      Thinking the patch as the first-line drug, it should be proven as safe for a long time. The&#xD;
      safety and clinical effect of Exelon patch was tested in many studies.&#xD;
&#xD;
      However, most of studies have been conducted on Western countries and the study period was&#xD;
      not more than a year.&#xD;
&#xD;
      There are only few data on Exelon patch related to other ethnic such as Asian patients with&#xD;
      Alzheimer's disease.&#xD;
&#xD;
      Especially, there are many different environmental factors between Western and Asia&#xD;
      countries, such as habitual or climate factors, skin type and behavioral styles which may be&#xD;
      influenced on patch durability.&#xD;
&#xD;
      The aim of this study was to evaluate the durability of Exelon patch in Korean patients with&#xD;
      Alzheimer's disease and what are the factors influencing the durability.&#xD;
&#xD;
      Also evaluating the significance of factors gives us the way to increase the patch&#xD;
      durability.&#xD;
&#xD;
      Thirty patients per investigational center will be enrolled during 6 months.&#xD;
&#xD;
      Probable mild to moderate AD patients will be included whether they have depression or other&#xD;
      neurological symptoms or diseases.&#xD;
&#xD;
      The period of this study will be 6 months, and we will start the treatment starting from&#xD;
      Exelon patch 5cm2.&#xD;
&#xD;
      After 4 weeks, dose titration will be attempted to Exelon patch 10cm2.&#xD;
&#xD;
      If a patient is reporting too much discomfort to stick on high dose patch, investigators will&#xD;
      assess the severity of the side effects followed by adjusting dose or considering&#xD;
      discontinuation.&#xD;
&#xD;
      Cognitive, functional, and global outcome measures are obtained at baseline and at the end of&#xD;
      month 6. Environmental factors including caregiver condition, participant's habitat type, and&#xD;
      participant's skin type, etc. are also evaluated from the first visit, and they will be&#xD;
      assessed at every visit.&#xD;
&#xD;
      Participants and their caregivers will be asked of any possible concerns or problems&#xD;
      associated with patch use at every visit. And if there is any visible problem or adverse&#xD;
      event, it will be taken as a picture and be uploaded to investigation web site for this&#xD;
      study.&#xD;
&#xD;
      Finally, for the primary endpoint, participants who discontinue prematurely are evaluated&#xD;
      during every visit.&#xD;
&#xD;
      Signs of skin irritation at the site of patch application are assessed at every visit by the&#xD;
      investigator using skin irritation rating scale.&#xD;
&#xD;
      Caregivers evaluate patch adhesion throughout the study with ratings provided in accordance&#xD;
      with a patch adhesion scoring system.&#xD;
&#xD;
      To assess factors to influence skin irritation or any other adverse events, we will classify&#xD;
      skin type of each participant using &quot;skin type measuring paper&quot; at the first visit time.&#xD;
&#xD;
      We will search for any personal or family history of allergy, and characteristics of&#xD;
      participant's habitat using questionnaire.&#xD;
&#xD;
      The information about the caregiver including his/her condition based on the annual income,&#xD;
      living status, and education level.&#xD;
&#xD;
      To see if there is any specific allergic factor for discontinuation, we will investigate&#xD;
      participant's allergy history more completely and thoroughly.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2009</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with adverse events</measure>
    <time_frame>24 weeks</time_frame>
    <description>number of participants with skin irritation or other adverse events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Factors for the disuse of Rivastigmine patch</measure>
    <time_frame>24 weeks</time_frame>
    <description>to search for the factors that affect the disuse of Rivastigmine patch in each patient, such as skin irritation,abnormal clinical laboratory factors, or environmental factors.</description>
  </secondary_outcome>
  <enrollment type="Actual">300</enrollment>
  <condition>Alzheimer's Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Rivastigmine patch</intervention_name>
    <description>Rivastigmine patch (5-10cm2, daily, 24hr)</description>
    <other_name>Exelon patch</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Alzheimer's disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Probable AD by NINCDS-ADRDA and DSM-IV&#xD;
&#xD;
          -  Male and female aged from 51 to 85 years old&#xD;
&#xD;
          -  Magnetic resonance imaging or computed tomographic scan within 12 months consistent&#xD;
             with a diagnosis of probable AD&#xD;
&#xD;
          -  Patients who approved to release of personal information&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with any active pulmonary, gastrointestinal, renal, hepatic (severe hepatic&#xD;
             function impaired patients), endocrine, or cardiovascular disease, clinically&#xD;
             significant laboratory abnormalities, or any medical condition which would prohibit&#xD;
             them from completing the study&#xD;
&#xD;
          -  Any patients suspicious of drug addiction or alcohol addiction for the past 10 years&#xD;
&#xD;
          -  Any other patients to be decided to be inappropriate for the study by the&#xD;
             investigators&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>51 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SangYun Kim, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University College of Medicine &amp; Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dong Won Yang, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>The Catholic University of Korea</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Moon Ho Park, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Korea University College of Medicine &amp; Korea University Ansan Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hae Ri Na, MD</last_name>
    <role>Study Director</role>
    <affiliation>Bobath Memorial Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Young-Chul Yoon, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chungang University College of Medicine &amp; Chungang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seong-Ho Koh, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University College of Medicine &amp; Hanyang University Guri Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyun Jeong Han, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kwandong University College of Medicine &amp; Myongji Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bon D. Ku, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kwandong University College of Medicine &amp; Myongji Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seong-Hye Choi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inha University College of Medicine &amp; Inha University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jung Seok Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jeju National University College of Medicine &amp; Jeju National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jun-Seong Lim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SungAe General Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jung Eun Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ewha Womans University School of Medicine &amp; Ewha Womans University Mokdong Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jeong Yeon Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inje University College of Medicine &amp; Sanggye Paik Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hee-Jin Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University College of Medicine &amp; Hanyang University Seoul Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Seung Hyun Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hanyang University College of Medicine &amp; Hanyang University Seoul Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Key Hung Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kyung Hee University College of Medicine &amp; Kyung Hee University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kyung Won Park, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dong-A University College of Medicine &amp; Dong-A University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hui Chul Choi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hallym University College of Medicine &amp; Hallym University Chunchon Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eun-Joo Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pusan National University School of Medicine &amp; Pusan National University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bora Yoon, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Konyang University School of Medicine &amp; Konyang University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hyun Duk Yang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wonkwang University College of Medicine &amp; Wonkwang University Sanbon Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Youngsoon Yang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yong-in Hyoja Geriatric Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hee-Jung Seo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yong-in Hyoja Geriatric Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Korea University Ansan Hospital</name>
      <address>
        <city>Ansan</city>
        <state>Gyeonggi-do</state>
        <zip>425-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Myongji Hospital</name>
      <address>
        <city>Goyang-si</city>
        <state>Gyeonggi-do</state>
        <zip>412-270</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wonkwang University Sanbon Medical Center</name>
      <address>
        <city>Gunpo-si</city>
        <state>Gyeonggi-do</state>
        <zip>435-040</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanyang University Guri Hospital</name>
      <address>
        <city>Guri-si</city>
        <state>Gyeonggi-do</state>
        <zip>471-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bobath Memorial Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>463-480</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yong-in Hyoja Geriatric Hospital</name>
      <address>
        <city>Yongin-si</city>
        <state>Gyeonggi-do</state>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dong-A University Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusan National University Hospital</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hallym University Chunchon Hospital</name>
      <address>
        <city>Chunchon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Konyang University Hospital</name>
      <address>
        <city>Daejeon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inha University Hospital</name>
      <address>
        <city>Incheon</city>
        <zip>400-711</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jeju National University Hospital</name>
      <address>
        <city>Jeju</city>
        <zip>690-756</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul St. Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>137-701</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SungAe General Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>150-051</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chungang University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>156-755</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ewha Womans University Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hanyang University Seoul Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kyung Hee University Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sanggye Paik Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <study_first_submitted>October 26, 2010</study_first_submitted>
  <study_first_submitted_qc>March 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2011</study_first_posted>
  <last_update_submitted>May 2, 2016</last_update_submitted>
  <last_update_submitted_qc>May 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>SangYun Kim</investigator_full_name>
    <investigator_title>Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital</investigator_title>
  </responsible_party>
  <keyword>Alzheimer's disease</keyword>
  <keyword>Rivastigmine</keyword>
  <keyword>Patch</keyword>
  <keyword>Tolerability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rivastigmine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

